type 2 diabetes glp-1 drugs are all approved for glucose control in (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None New GLP-1 Guidelines for Type

IV NAD+ therapy promotes cell regeneration throughout the body, from the brain to the skin and muscles

Possible shared pathways may be related to insulin regulation, suggesting that diabetes drugs may possess neuroprotective effects (Holst et al., 2011)

M.AnJ.et al (2015)

It is not as simple as that

"I do think we need to have a bit more compassion for ourselves and be a little more gentle with ourselves, and not put so much pressure on ourselves to be a certain way or a certain ideal." For support with eating disorders and body dissatisfaction, call the Butterfly National Helpline on 1800 ED HOPE (1800 33 4673) or visit www.butterfly.org.au to chat online or email, 7 days a week, 8am-midnight (AEST).